Delivery Order SPE2DB24D2101-SPE2DB25FKPSA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Pioglitazone HCL 15 mg tablets (30-count units) with a ceiling value of $1,142.37 and a firm fixed price structure. The order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date is set for...
- The Defense Logistics Agency awarded a delivery order valued at $2,663.37 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 15 mg tablets (90-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitively awarded delivery order procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pioglitazone HCL 15 mg tablets in a quantity of 90 count, valued at $1,904.05. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of October 22, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $3,170.20. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 17,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units) valued at $2,474.49. This non-competitive delivery order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a firm fixed-price transaction under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pioglitazone HCL 30 mg tablets in a quantity of 500 units. This is a firm fixed-price delivery order valued at $1,502.62, with an ultimate completion date of September 23, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,847.10 for Pioglitazone HCL 45 mg tablets (90-count) on September 23, 2025, with a completion date of September 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical, a comprehensive $1...
- The Defense Logistics Agency awarded a $3,498.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The Defense Logistics Agency awarded a delivery order valued at $6,579.31 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 30 mg tablets (30-count packages) on November 13, 2025, with completion expected by November 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,139.20 to supply Pioglitazone HCL 15 mg tablets (quantity: 90 count) with delivery to the company's distribution facility in Conshohocken, Pennsylvania. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and carries an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPSADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count) at a firm fixed price of $3,758.40, with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs and federal medical supply chains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in meeting federal procurement requirements through competitive awards across multiple therapeutic domains. The company's extensive portfolio of federal contracts encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical supplies. This award represents one of numerous delivery orders the company fulfills under its DLA Troop Support Medical contract, supporting critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded without set-aside designations, underscoring its competitive positioning in the federal pharmaceutical distribution market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/17/25 |